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Abstract 
New cobalt (II) complex has been synthesized and characterized by elemental analysis, 
UV-Vis, FT-IR and thermal analysis. Binding of this Co (II) complex with calf thymus DNA 
was investigated by UV-Visible absorption, fluorescence spectroscopy techniques. The intrinsic 
binding constants Kb of complex with CT-DNA obtained from UV-Vis absorption studies were 
4.43 × 105M-1. Further, the in vitro cytotoxic effect of the complexes examined on cancerous cell 
line, such as human breast cancer cells (MCF-7).  
Keywords: Co (II) complex, DNA interaction and cytotoxicity activity. 
1. Introduction 
Cobalt is an essential trace element in humans, exhibiting many useful biological 
functions. Numerous compounds, naturally occurring and man-made, contain the cobalt at two 
common oxidation state Co (II) and Co (III) There is growing interest in investigating cobalt and 
other transition metal complexes for their interaction with DNA [1-5]Deoxyribonucleic acid 
plays an important role in the life process, because it bears heritage information and instructs the 
biological synthesis of proteins and enzymes through the replication and transcription of genetic 
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information in living cells. DNA is a particularly good target for metal complexes as it offers a 
wide variety of potential metal binding sites [6,7]. Transition metal complexes with beta-
diketones are known to possess bacteriocidal. Antiviral, antifungal and antialgal activities [8]. 
Metal complexes having N, O donor atoms are very important because of their significant 
biological properties such as antibacterial, antifungal, anticancer and herbicidal [9]. Cobalt is an 
essential trace element in humans, exhibiting many useful biological functions. Numerous 
compounds, naturally occurring and man-made, contain the cobalt at two common oxidation 
states Co(II) and Co(III). There is growing interest in investigating cobalt and other transition 
metal complexes for their interaction with DNA. This may be partly influenced by the results of 
extensive investigation into two areas of research, viz (i) the binding specificity of small organic 
molecules for their possible modulation and inhibition of DNA replication, transcription and 
recombination, and (ii) anticancer, antiviral and antibacterial drugs [10,11]. The interest on 
cobalt complexes in experimental cancer therapy research results from their role as systemic 
anticancer agents and their ability to redox-dependent targeting the tissue of solid tumours. The 
former role was firstly attrubuted to the fact that vitamin B12 (cobalamin) is substituted together 
with folic acid in chemotherapy regimens involving antimetabolites to reduce unwanted side 
effects, and, secondly, to the fact that fast proliferating cells require higher amounts of vitamins 
B12 than normal ones [12].  Since the first reported studies into the biological activity of Co 
complexes [13] in 1952, diverse structurally characterized cobalt complexes showing antitumor 
anti-proliferative [14,15], antimicrobial [16,17], antifungal [18,19], antiviral [20,21] and 
antioxidant [22] activities have been reported. 
Accordingly, we intend to report herein, the synthesis of Co(II) complex with  2-
hydroxy-1-naphthaldehyde and ethylenediamine ligand and characterization of complex was 
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carried out by elemental analysis, IR, UV-Vis and thermal studies. The binding properties of this 
complex to CT-DNA have been carried out using different physico-chemical methods and the 
binding modes are discussed. 
 
2. Physical measurements 
Elemental analyses of carbon, hydrogen, and nitrogen were performed on a Carlorerba-
1106 microanalyzer. The electronic spectra were recorded on a Shimadzu UV-3101PC 
spectrophotometer. FT-IR spectra were recorded in the 4000–400 cm-1 region using KBr pellets 
on a Bruker EQUINOX 55 spectrometer.  The fluorescence study was carried out on an Elico SL 
174 spectrofluorometer. The molar conductivity of a freshly prepared solution of the complexes 
(10-3 M) in DMF was measured using an Elico Model SX80 conductivity bridge.  
2.2. Absorption spectrophotometric studies 
 Absorption spectra titrations were performed at room temperature in Tris-HCl/NaCl 
buffer (50 mMTris-HCl/1 mMNaCl buffer, pH 7.5) to investigate the binding affinity between 
CT-DNA and complex. 2 mL solutions of the blank Tris–HCl/NaCl buffer and the Co(II) 
complex sample ([complex] = 5 × 10−6 M) were placed into two 1 cm path cuvettes, respectively. 
Then one aliquot (10 μL) of buffered CT-DNA solution (0.01 M) was added to each cuvette in 
order to eliminate the absorbance of DNA itself. Before the absorption spectra were recorded, the 
Co(II)-DNA solutions were incubated at room temperature for 5 min in order to full reaction. 
2.3. Competitive Binding Experiments 
 The relative binding of complexes to CT-DNA were determined with an EB-bound CT-
DNA solution in Tris–HCl/NaCl buffer (pH=7.2, 5 mMTris–HCl, 50 mMNaCl). The 
experiments were carried out by adding a certain amount of a solution of complexes ([complex] 
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= 1.0 × 10−3 M) step by step into the EB–DNA solution (2.4 μM EB and 48 μM CT-DNA). The 
influence of the addition of complexes to the EB-DNA complex have been obtained by recording 
the variation of fluorescence emission spectra with excitation at 510 nm and emission at 602 nm. 
Before the emission spectra were recorded, the Co(II)-DNA solutions were incubated at room 
temperature for 5 min in order to full reaction. 
2.4. Cell culture 
The MCF-7 human breast cancer cell line was obtained from National Center for Cell 
Sciences (NCCS), Pune, India. The cell line was cultured in the Dulbecco’s Modified Eagles 
medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 200 mM L-glutamine, 100 
U/mL penicillin, and 10 mg/mL streptomycin in a humidified atmosphere consisting of 5% CO2 
at 37º C.  
2.5. Evaluation of cytotoxicity  
 The cytotoxic effect of complexes (1-3) against MCF-7 cells was evaluated by MTT [3-
(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. Briefly, MCF-7 cells were 
seeded (5 × 104 cells/well) in a 96-well plate and kept in CO2 for attachment and growth for 24 h. 
Then, the cells were treated with various concentrations of complexes dissolved in DMSO (0.25-
100 µM) and incubated for 24 h. After incubation, the culture medium was removed and 15 μL 
of the MTT solution (5 mg/mL in PBS) was added to each well. Following 4 h incubation in 
dark, MTT was discarded and DMSO (100 μL/well) was added to solubilize the purple formazan 
product. The experiment was carried out in triplicates and the medium without complex served 
as control. The absorbance was measured colorimetrically at 570 nm using an ELISA microplate 
reader. The percentage of cell viability was calculated using the following formula and expressed 
as IC50; 
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 % cell viability= (OD value of treated cells)/ (OD value of untreated cells (control) ×100 
  The IC50 value is calculated using linear regression from excel. 
 
2.6. Synthesis of complex  
2.6.1.[Co(L3).NCS]  
To a solution of 2-hydroxy-1-naphthaldehyde (0.144 g, 0.84 mmol) in methanol (10 ml), 
sodium hydroxide (0.03 g, 0.84 mmol) was added and the resulting solution was stirred for 15 
min at room temperature. CoCl2.6H2O (0.20 g, 0.84 mmol) in methanol (10 ml) followed by 
ethylenediamine (0.05 g, 0.84 mmol) in methanol (10 ml) were added to the solution. To the 
reaction mixture ammonium thiocyanate (0.081 g, 0.84 mmol) are added, followed by stirring for 
3 h. The green colored precipitate that formed. Yield: 59 %; (0.17g). m.p. 143 °C (dec). Anal. 
Calc. (%) for C14H13CoN3OS: C, 50.21; H, 3.91; N, 12.55; S, 9.57. Found (%): C, 49.95; H, 
4.09; N, 12.30; S, 9.36.FT-IR (KBr, ν, cm–1 selected peaks: 3550br, 3420s, 2068, 1720s, 1629s, 
1602s, 1567s, 1525s, 1478s, 1447s, 1343s, 1295s, 1157s, 1157s, 1096s, 1064s, 1032s, 762s, 
698s, 531s, 520s, 509s (br, broad; s, sharp). UV-Vis in DMF [λmax/nm (εmax/ mol-1 cm-1)]: 
271(4999), 279(3610), 303(2875), 315(2730), 402(179).  ESI-MS (CH3OH) m/z (%): 330(10%) 
[M+].Conductivity (ΛM/S cm2 mol-1) in DMF: 14.  
The complexes [Ni(L2).NCS] (8) and [Cu(L2).NCS] (9) were synthesized by following 
the above procedure using cobaltous chloride instead of using Nickel chloride (1.99 g, 0.84 
mmol) and copper chloride (0.14 g), respectively. 
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3. Results and discussion 
3.2. IR and UV/Vis spectroscopy 
 There are conspicuous differences between the complex and free ligand in IR spectrum 
[23]. In the free ligand amedium-intensity band at 3187.66 cm−1, assigned to υ(OH) of diketone 
tautomer, and two strong bands around 1675.05 and 1017.66 cm−1, due to (C O) of the lateral 
chain and (C O) of pyrazolone ring respectively, are absent in the complex [24]. In the complex, 
there are four new bands at 2987.66 cm−1, 1985.81 cm−1 and 563.60 cm−1, respectively, assigned 
to [υ(C―O−)], υ(C C C), water molecules [25] and Co―O, respectively (Fig. 1). 
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Fig. 1.FT-IR analysis of complex 1. 
 
 UV–vis absorption spectra of complex in ethanolicsolutionwere recorded in 
thewavelength range 200–800 nm. Two absorptions of the complex at 269, 293 nm are attributed 
to л−л* transitions of aryl ring, carbonyl, and n−л* transition of carbonyl [26]. In the visible 
region, weaker absorptions near 607 and 672 nm for the Co(II) complex are assigned as 
4T1g→4A2g, 4T1g→4T2g (F) for d–d transitions, consistentwith Co in an octahedral 
environment (Fig. 2). 
 
Fig.2. UV-Vis analysis of complex 1. 
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3.3. Thermal studies 
 Thermogravimetric (TG) and differential thermogravimetric (DTA) analysis (Fig.3) were 
carried out for the complex 1 under nitrogen flow at the constant heating of 10°C per minute. 
The thermogram of this complex decomposition observed in the range 100-200°C (50% 
corresponds to the weight loss 2-hydroxy-1-naphthaldehyde and ethylenediamine moiety present 
in the complex 1. There are four DTA endotherm peak observed at 55.85, 86.08, 138.09 and 
168.79°C, respectively, also confirmed the decomposition and weight loss of ligand moieties. 
The residue left in the crucible consists of corresponding metal oxide [27].  
 
Fig.3. Thermal analysis of complex 1. 
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3.4. DNA binding studies 
3.4.1. Study of the interaction of the complexes with CT DNA with UV spectroscopy 
 Transition metal complexes can bind to DNA via both covalent (via replacement 
of a labile ligand of the complex by a nitrogen base of DNA) and/or noncovalent (intercalation, 
electrostatic or groove binding) interactions [28]. In the literature, a metal complex has been 
found to bind to DNA via the intercalative mode [29]. The UV spectra have been recorded for a 
constant CT DNA concentration in different [complex]/[DNA] mixing ratios. UV spectra of CT 
DNA in the presence of a compound derived for diverse r values are shown representatively for 
Fig. 6. The band at max = 258 nm exhibits a red-shift up to 2 nm for all compounds, indicating 
that the interaction with CT DNA results in the direct formation of a new complex with double-
helical CT DNA [30] with a simultaneous stabilization of the CT DNA duplex [31]. In the UV 
spectra of the complex, the intense absorption bands observed are attributed to the intra-ligand 
transitions of the coordinated groups of acetylacetone ligands. Any interaction between complex 
and CT DNA that could perturb its intraligandcentred spectral transitions during the titration 
upon addition of CT DNA in diverse r values can be observed [32]. In general, the changes 
observed in the UV spectra upon titration may give evidence of the existing interaction mode, 
since a hypochromism due to π-π* stacking interactions may appear in the case of the 
intercalative binding mode, while red-shift (bathochromism) may be observed when the DNA 
duplex is stabilized [33]. According to linear Stern-Volmer equation: [34], 
 Journal of Advanced Applied Scientific Research ISSN: 2454-3225  
S. Kadhiravan et.al JOAASR-ICCER-JANUERY-2017 
 
 
 
Fig. 4.Absorption spectra of complex 1 in 5 mMTris-HCl/buffer upon addition of DNA. The 
inner plot of [DNA/(εa-εf) vs [DNA] for the titration of DNA with complex 
 
I0/I=1+Ksvr, 
whereI0and I are the fluorescence intensities in the absence and the presence of complex. 
Ksvis a linear Stern-Volmer quenching constant, r is the ratio of the total concentration of 
complex to that of DNA. The quenching plot illustrates that the quenching of EB bound to DNA 
by the complexes is in good agreement with the linear Stern-Volmer equation, which also 
indicated that the complexes binds to DNA. In the plot of I0/I versus [Complex]/[DNA], Ksv is 
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given by the ratio of the slope to intercept. The Ksvvalue for our complex thus obtained is 4.43 × 
105M-1,respectively. This may suggest that the complex 1 has intercalative mode of binding that 
involves a stacking interaction between the complexes and the base pairs of DNA. 
 
3.4.2. Competitive study with ethidium bromide 
 Ethidium bromide (EB) is a typical indicator of intercalation since it can form soluble 
complexes with nucleic acids resulting in the emission of intense fluorescence due to the 
intercalation of the planar phenanthridine ring between adjacent base pairs on the double helix of 
CT DNA. The changes observed in the spectra of EB on its binding to CT DNA are often used 
for the interaction study between DNA and metal complex [35]. Complex 1 shows no 
fluorescence at room temperature in solution or in the presence of CT DNA, and their binding to 
DNA cannot be directly predicted through the emission spectra (Fig. 5). Hence competitive EB 
binding studies may be undertaken in order to examine the binding of each compound with DNA 
since the fluorescence intensity is highly enhanced upon addition of CT DNA, due to its strong 
intercalation with DNA base pairs. Addition of a second molecule, which may bind to DNA 
more strongly than EB, results in a decrease the DNA-induced EB emission due to the 
replacement of EB, and/or electron transfer [36,37].  
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Fig. 5.Fluorescence emission spectra of the EB-DNA in presence of complex 1 in 5mM TrisHCl 
buffer (pH 7.2). The inner plot of [I0/I] vs complex concentration.  
 
 The emission spectra of EB bound to CT DNA in the absence and presence of each 
compound have been recorded for [EB] = 20 mM, [DNA] = 26 mM for increasing amounts of 
each compound. The addition of complex 1 at diverse r values (Fig. 6) results in a significant 
decrease of the intensity of the emission band of the DNA-EB system at 592 nm indicating the 
competition of the complex with EB in binding to DNA. The observed significant quenching of 
DNA-EB fluorescence for complex 1 suggests that they displace EB from the DNA-EB complex 
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1 and they can probably interact with CT DNA by the intercalative mode [38]. The Stern-Volmer 
constant Ksv may be used to evaluate the quenching efficiency for each compound according to 
the equation: 
I0/I=1+Ksvr, 
 whereI0 and I are the emission intensities in the absence and the presence of the quencher, 
respectively, [Q] is the concentration of the quencher and Ksv is obtained by the slope of the 
diagram I0/Ivs [Q]. The Ksvvalue for our complex thus obtained is 3.9 × 10
4 M-1,respectively. 
The Stern-Volmer plots of DNA-EB for the compounds illustrate that the quenching of EB 
bound to DNA by the compounds is in good agreement (R = 0.9983) with the linear 
SterneVolmer equation, which proves that the replacement of EB bound to DNA by each 
compound results in a decrease in the fluorescence intensity.  
3.4.3. Circular dichroism 
 CD spectroscopic technique can be successfully utilized to detect the conformational 
changes of DNA induced by its interaction with metal complex. The CD spectrum of CT-DNA 
was recorded in the range 220–320 nm in 0.1 M phosphate buffer (pH 7.2) and it has been found 
that there were one positive band at 275 nm due to base stacking and one negative band at 245 
nm due to helicity [39]. The examination of Fig. 7 indicates that the positive band slightly 
increased in intensity and the negative band decreased in intensity after the binding of complex 
with DNA however no considerable shift in max could be observed. A very small decrease in 
the intensity of positive band and a small increase in the intensity of negative band were 
observed when the DNA. Intercalation binding interaction of the complex with DNA have been 
shown to bring about only marginal changes in the intensity of negative band as well as the 
positive band of DNA and no significant shift observed positive and negative band. 
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Fig. 6. CD spectra of CT-DNA (1.0 x 10-4 M), and the interaction with complex1 
([complex]/[DNA] = 0.5). All the spectra were recorded in 5 mMTris–HCl/ 50 mMNaCl buffer, 
pH 7.2 and 25 °C. 
 
3.4.4. Interaction of the complexes with serum albumin proteins 
 It is important to consider the interactions of drugs with blood plasma proteins 
particularly with serum albumin, which is the most abundant protein in plasma and is involved in 
the transport of metal ions and metal complex with drugs through the blood stream. Binding to 
these proteins may lead to loss or enhancement of the biological properties of the original drug, 
or provide paths for drug transportation [40]. Bovine serum albumin (BSA) is the most 
extensively studied serum albumin, due to its structural homology with human serum albumin 
(HSA). BSA (containing two tryptophans, Trp-134 and Trp-212) solutions exhibit a strong 
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fluorescence emission with a peak at 343 nm, respectively, due to the tryptophan residues, when 
excited at 295 nm [41]. The interaction of complex 1 with serum albumins has been studied from 
tryptophan emission-quenching experiments. The changes in the emission spectra of tryptophan 
in BSA are primarily due to change in protein conformation, subunit association, substrate 
binding or denaturation. Complexes 1 exhibited a maximum emission at 355 nm (Fig. 7) under 
the same experimental conditions and the SA fluorescence spectra have been corrected before 
the experimental data processing [42]. Addition of complex 1 to BSA results in relatively low 
fluorescence quenching (Fig.7), due to possible changes in protein secondary structure of BSA 
indicates the binding of the compounds to BSA [43]. The Stern–Volmer and Scatchard graphs 
may be used in order to study the interaction of a quencher with serum albumins. According to 
Stern–Volmer quenching equation : 
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Fig.7.Fluorescence spectra of BSA in presence of various concentration of complex1. 
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Fig.8.Plot of % relative fluorescence intensity at λem = 355 nm (I/I0 (%)) vs 
(r = [compound]/[BSA]) for complex1  in buffer solution (pH 7.0). 
𝐼0
𝐼
= 1 + 𝑘𝑞0[𝑄] =  1 + 𝐾SV[Q] 
whereI0 = the initial tryptophan fluorescence intensity of SA, I = the tryptophan 
fluorescence intensity of SA after the addition of the quencher, kq = the quenching rate constants 
of SA, Ksv = the dynamic quenching constant, 0 = the average lifetime of SA without the 
Aquencher, [Q] = the concentration of the quencher respectively,  
𝐾sv = 𝑘𝑞0 
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and, taking as fluorescence lifetime (0) of tryptophan in SA at around 10-8s, the dynamic 
quenching constant (Ksv, M
-1) can be obtained by the slope of the diagram I0 /Ivs [Q] (Fig. 8), and 
subsequently the approximate quenching constant (kq, M
-1 s-1) may be calculated. The calculated 
values of Ksv and kq for the interaction of the compounds with BSA are given in    Table 3 and 
indicate a good BSA binding propensity of the complexexhibiting the highest BSA quenching 
ability. The kq values are higher than diverse kinds of quenchers the existence of a static 
quenching mechanism . Using the Scatchard equation [44, 45]: 
 
Fig. 9.Fluorescence spectra of BSA in emission intensity I0/I vs [Q]. [Q = complex] 
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∆𝐼 𝐼0⁄
[𝑄]
=  𝑛𝐾 − 𝐾 (
∆𝐼
𝐼0
) 
 where n is the number of binding sites per albumin and K is the association binding 
constant, K (M-1), may be calculated from the slope in plots (I0/I)/[Q] versus (I/I0) (Fig. 9) and 
n is given by the ratio of the y intercept to the slope.  The K values of the complexes (1-3) for 
albumins, being in the value given Table 3. The Stern-Volmer equation applied for the 
interaction with BSA in Fig. 12 shows that the curves have fine linear relationships (r = 0.9921). 
The calculated values of Ksv, n and kq are given in Table 3 and indicate their good BSA binding 
propensity with complexes. From the Scatchard graph (Fig. 10], the association binding constant 
to BSA of each compound has been calculated (Table 3) with complex 2 exhibiting higher K 
values than other complexes. Therefore, the study of the binding to albumins may reveal useful 
information concerning future application. 
Table 3.The BSA binding constant and parameters (Ksv, kq, K, n and r) derived for complex1. 
Compound Ksv(M
-1) kq(M
-1s-1) K(M-1) N R 
Complex 1 5.5 × 104 5.5 × 1012 0.0845 0.0932 0.9921 
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Fig.10.Determination of the complex-BSA binding constant and the number of binding sites of 
BSA. 
 
3.8. Cytotoxic activity 
Cytotoxic potential of newly synthesized complex 1 was investigated on human breast 
cancer cell (MCF-7). The complex 1 were applied in range of concentration 0.25-100 µM for 
MCF-7 and left for 48 h. The activities of the complexes were determined by MTT test in vitro 
and the results were expressed in terms of IC50 values. The relations of inhibition rates and 
complexes concentrations against human breast cancer cell (MCF-7) were shown in Fig.11. The 
 Journal of Advanced Applied Scientific Research ISSN: 2454-3225  
S. Kadhiravan et.al JOAASR-ICCER-JANUERY-2017 
 
 
inhibition effects were further enhanced by increasing the concentration of complexes. At the 
concentration of 100 µM, inhibition rates of the complex 1 against human breast cancer cells 
reached nearly same values. The values of IC50 for the complex 1 were 100 µM. It is commonly 
believed that the biological activities of anticancer metal complex are dependent on their ability 
to bind DNA and damage its structure resulting in the impairment of its function, which is 
followed by inhibition of replication, transcription processes and eventually cell death, if the 
DNA lesions are not properly repaired. The type of metal ion may be another reason for their 
different anticancer activity [42]. This is due to the fact that cobalt complexes have the capacity 
to reduce the energy status in tumors, as well as to enhance tumor hypoxia, which also influences 
their antitumor activities.  
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Fig. 11.Cytotoxic effect of complexes (1-3)against MCF-7 at different concentration. Cell 
viability decreased with increasing concentration of complex1. 
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3.9. Conclusions 
The complex [Co] has been synthesized and characterized. Complex1bind to CT DNA 
through intercalative binding mode. The complex shows good binding affinity to BSA proteins 
and to give relatively high binding constant. The in vitro cytotoxicity study on breast cancer cell 
line (MCF-7) indicates that complex has the potential to act aseffective anticancer drug. These 
studies form an important rationale for drug design and warrant further in vivo experiments and 
pharmacological assays. 
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